London Company of Virginia’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $479K | Hold |
17,061
| – | – | ﹤0.01% | 148 |
|
|
2025
Q4 | $425K | Sell |
17,061
-16,444
| -49% | -$415K | ﹤0.01% | 159 |
|
|
2025
Q3 | $854K | Sell |
33,505
-17,122
| -34% | -$423K | ﹤0.01% | 146 |
|
|
2025
Q2 | $1.23M | Sell |
50,627
-25,640
| -34% | -$598K | 0.01% | 139 |
|
|
2025
Q1 | $1.93M | Sell |
76,267
-33,341
| -30% | -$872K | 0.01% | 132 |
|
|
2024
Q4 | $2.91M | Sell |
109,608
-929,462
| -89% | -$25.2M | 0.02% | 129 |
|
|
2024
Q3 | $30.1M | Sell |
1,039,070
-31,429
| -3% | -$917K | 0.16% | 93 |
|
|
2024
Q2 | $30M | Sell |
1,070,499
-57,366
| -5% | -$1.58M | 0.17% | 90 |
|
|
2024
Q1 | $31.3M | Buy |
1,127,865
+154,146
| +16% | +$4.28M | 0.16% | 88 |
|
|
2023
Q4 | $28M | Sell |
973,719
-1,784,711
| -65% | -$54M | 0.16% | 91 |
|
|
2023
Q3 | $91.5M | Sell |
2,758,430
-4,518,686
| -62% | -$160M | 0.55% | 59 |
|
|
2023
Q2 | $267M | Sell |
7,277,116
-175,201
| -2% | -$6.82M | 1.51% | 23 |
|
|
2023
Q1 | $304M | Sell |
7,452,317
-198,592
| -3% | -$8.58M | 1.76% | 16 |
|
|
2022
Q4 | $392M | Buy |
7,650,909
+4,181
| +0.1% | +$200K | 2.31% | 10 |
|
|
2022
Q3 | $335M | Buy |
7,646,728
+196,013
| +3% | +$9.52M | 2.12% | 9 |
|
|
2022
Q2 | $391M | Sell |
7,450,715
-243,878
| -3% | -$12.4M | 2.39% | 7 |
|
|
2022
Q1 | $398M | Buy |
7,694,593
+265,281
| +4% | +$13.8M | 2.1% | 11 |
|
|
2021
Q4 | $439M | Buy |
7,429,312
+3,171
| +0% | +$157K | 2.21% | 8 |
|
|
2021
Q3 | $319M | Buy |
7,426,141
+172,670
| +2% | +$7.65M | 1.75% | 18 |
|
|
2021
Q2 | $284M | Buy |
7,253,471
+55,739
| +0.8% | +$2.17M | 1.51% | 27 |
|
|
2021
Q1 | $261M | Sell |
7,197,732
-11,070
| -0.2% | -$393K | 1.5% | 28 |
|
|
2020
Q4 | $265M | Sell |
7,208,802
-300,817
| -4% | -$11M | 1.66% | 20 |
|
|
2020
Q3 | $261M | Buy |
7,509,619
+34,911
| +0.5% | +$1.22M | 1.86% | 17 |
|
|
2020
Q2 | $232M | Buy |
7,474,708
+170,245
| +2% | +$5.78M | 1.8% | 18 |
|
|
2020
Q1 | $226M | Sell |
7,304,463
-321,075
| -4% | -$10.9M | 2.16% | 10 |
|
|
2019
Q4 | $283M | Sell |
7,625,538
-140,163
| -2% | -$4.99M | 2.18% | 9 |
|
|
2019
Q3 | $265M | Buy |
7,765,701
+2,553,395
| +49% | +$92.9M | 2.18% | 10 |
|
|
2019
Q2 | $214M | Buy |
5,212,306
+22,589
| +0.4% | +$897K | 1.84% | 19 |
|
|
2019
Q1 | $209M | Sell |
5,189,717
-84,305
| -2% | -$3.38M | 1.79% | 20 |
|
|
2018
Q4 | $218M | Sell |
5,274,022
-389,536
| -7% | -$16.2M | 2.09% | 10 |
|
|
2018
Q3 | $237M | Sell |
5,663,558
-118,926
| -2% | -$4.58M | 1.84% | 16 |
|
|
2018
Q2 | $199M | Sell |
5,782,484
-108,707
| -2% | -$3.71M | 1.63% | 22 |
|
|
2018
Q1 | $198M | Sell |
5,891,191
-751,456
| -11% | -$25.8M | 1.59% | 21 |
|
|
2017
Q4 | $228M | Sell |
6,642,647
-554,054
| -8% | -$18.9M | 1.65% | 22 |
|
|
2017
Q3 | $244M | Sell |
7,196,701
-170,201
| -2% | -$5.47M | 1.75% | 18 |
|
|
2017
Q2 | $235M | Buy |
7,366,902
+32,748
| +0.4% | +$1.03M | 1.59% | 21 |
|
|
2017
Q1 | $238M | Buy |
7,334,154
+338,536
| +5% | +$10.7M | 1.57% | 22 |
|
|
2016
Q4 | $216M | Buy |
6,995,618
+868,498
| +14% | +$26.5M | 1.48% | 23 |
|
|
2016
Q3 | $197M | Buy |
6,127,120
+451,811
| +8% | +$15.1M | 1.47% | 23 |
|
|
2016
Q2 | $190M | Buy |
5,675,309
+210,672
| +4% | +$6.72M | 1.46% | 22 |
|
|
2016
Q1 | $154M | Sell |
5,464,637
-727,359
| -12% | -$20.8M | 1.26% | 34 |
|
|
2015
Q4 | $190M | Buy |
6,191,996
+684,045
| +12% | +$21.5M | 1.64% | 17 |
|
|
2015
Q3 | $164M | Buy |
5,507,951
+257,461
| +5% | +$8.26M | 1.52% | 25 |
|
|
2015
Q2 | $167M | Buy |
5,250,490
+747,566
| +17% | +$24.4M | 1.45% | 23 |
|
|
2015
Q1 | $149M | Buy |
4,502,924
+648,613
| +17% | +$20.6M | 1.37% | 31 |
|
|
2014
Q4 | $114M | Buy |
3,854,311
+448,885
| +13% | +$12.9M | 1.19% | 34 |
|
|
2014
Q3 | $95.5M | Buy |
3,405,426
+158,506
| +5% | +$4.45M | 1.07% | 40 |
|
|
2014
Q2 | $91.4M | Buy |
3,246,920
+306,734
| +10% | +$8.74M | 1% | 44 |
|
|
2014
Q1 | $89.6M | Buy |
2,940,186
+126,247
| +4% | +$3.76M | 1.01% | 41 |
|
|
2013
Q4 | $81.8M | Buy |
2,813,939
+476,082
| +20% | +$13.9M | 0.93% | 44 |
|
|
2013
Q3 | $63.7M | Buy |
2,337,857
+180,827
| +8% | +$4.92M | 0.87% | 44 |
|
|
2013
Q2 | $57.3M | Buy |
+2,157,030
| New | +$59.6M | 0.83% | 47 |
|
Other funds holding PFE
VCM
VPM
London Company of Virginia's PFE Position: Q1 2026 in Review
London Company of Virginia held its Pfizer (PFE) position steady in Q1 2026 at 17,061 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #148.
London Company of Virginia first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $439M in Q4 2021. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- London Company of Virginia held 17,061 shares of Pfizer worth $479K as of Q1 2026.
- London Company of Virginia left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up ﹤0.01% of London Company of Virginia's portfolio in Q1 2026, its #148 holding.
- London Company of Virginia first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- London Company of Virginia's Pfizer position peaked at $439M in Q4 2021.
- 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on London Company of Virginia's 13F filing for Q1 2026, filed 15 May 2026.